Insider sale
WEREWOLF THERAPEUTICS, INC.
$216.5K
300.82K shares
What this filing means
UBS ONCOLOGY IMPACT FUND L.P. plans to sell 300.82K shares of WEREWOLF THERAPEUTICS, INC. valued at approximately $216.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/1/2026ACC: 0001628280-26-029394
10% Owner
Since Apr 2021
300.82K
Shares to sell
$216.5K
Approx. market value
300.82K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
5/4/2021
300.82KTotal acquired300.82K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2021 | Private Placement Cash | 300.82K | — |
| Total | 300.82K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
300.82K
Market value
$216.5K
5/1/2026
Total
Units
300.82K
Value
$216.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/1/2026 | 300.82K | $216.5K | NASDAQ | Planned |
| Total | 300.82K | $216.5K | ||